Risk in cardiovascular disease : Merit of using risk reduction rather than absolute risk for lipid lowering drugs

Gelijkaardige items

• Should treatment recommendations for lipid lowering drugs be based on absolute coronary risk or risk reduction?
  door: Ramachandran, S, et al.
  Gepubliceerd in: (2000)
• Lipid lowering drugs in diabetes: Absolute risk reduction is what counts
  door: Lewis, L S
  Gepubliceerd in: (2006)
• Should treatment recommendations for lipid lowering drugs be based on absolute coronary risk or risk reduction?
  Gepubliceerd in: (2001)
• Residual cardiovascular risk in individuals on lipid-lowering treatment: quantifying absolute and relative risk in the community
  door: Lieb, Wolfgang, et al.
  Gepubliceerd in: (2018)
• Risk language and dialects: Expressing risk in relative rather than absolute terms is important
  door: Campbell, D M
  Gepubliceerd in: (1998)